Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL

Approval Number

SIN15594P

Drug Name

BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL

Product Name

BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL

Approval Date

December 10, 2018

Registrant

RANBAXY (MALAYSIA) SDN. BHD.

Licence Holder

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

Registrant

RANBAXY (MALAYSIA) SDN. BHD.

Licence Holder

RANBAXY (MALAYSIA) SDN. BHD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route of Administration

INTRAVENOUS, SUBCUTANEOUS

Medical Information

ATC Code

L01XX32

ATC Item Name

xl 01 xx 32

Manufacturer Information

Pharmaceutical Manufacturer

RANBAXY (MALAYSIA) SDN. BHD.

Manufacturers

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Active Ingredients

Ingredient Name

BORTEZOMIB

Strength

3.5mg/vial

Drug MonographBortezomib

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL - HSA Approval | MedPath